Literature DB >> 2206913

Molecular cloning and expression of the rat angiotensinogen gene.

J S Chan1, A H Chan, Q Jiang, Z R Nie, S LaChance, S Carrière.   

Abstract

To identify tissue- and hormonal-specific DNA control cis-elements in the rat gene, we have constructed fusion genes consisting of various lengths of the 5'-flanking region of the rat angiotensinogen gene linked to a human growth hormone (hGH) reporter gene and have introduced them into a subclone of rat pancreatic islet tumor cell line (1056A) which expresses the highest level of angiotensinogen mRNA. As a negative control, we have also introduced them into a human choriocarcinoma cell line (JEG-3), which does not express the endogenous angiotensinogen gene. The level of the expression of these fusion genes in these cells was determined by the level of immunoreactive hGH secreted into the culture medium. The expression of angiotensinogen-growth hormone (ANG-GH) fusion genes, pOGH (ANG N-1498/+18), pOGH (ANG N-688/+18), pOGH (ANG N-110/+18), pOGH (ANG N-53/+18), and pOGH (ANG N-35/+18) was 1.0, 1.8, 1.5, 12.0 and 3.0-fold higher, respectively, than the promoterless growth hormone expression vector (pOGH). The addition of dexamethasone (10(-6) M), aldosterone (10(-5) M), and thyroid hormone, L-T3 (10(-7) M), stimulated the expression of pOGH (ANG N-1498/+18) by 4.0-, 2.5-, and 2.0-fold above the control level, respectively. Combination of dexamethasone (10(-6) M), L-T3 (10(-7) M), and ethinyl-estradiol (10(-6) M) stimulated the expression of the pOGH (ANG N-1498/+18) to greater than 10-fold over the control. Ethinyl-estradiol (10(-6) M) or progesterone (10(-6) M) alone had no effect on the expression of the pOGH (ANG N-1498/+18).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206913     DOI: 10.1007/bf00862531

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity.

Authors:  H Ohkubo; K Nakayama; T Tanaka; S Nakanishi
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

2.  Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney.

Authors:  P J Harris; J A Young
Journal:  Pflugers Arch       Date:  1977-01-17       Impact factor: 3.657

Review 3.  Cellular biology of the renin-angiotensin systems.

Authors:  R N Re
Journal:  Arch Intern Med       Date:  1984-10

4.  Common structural organization of the angiotensinogen and the alpha 1-antitrypsin genes.

Authors:  T Tanaka; H Ohkubo; S Nakanishi
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

5.  Lambda replacement vectors carrying polylinker sequences.

Authors:  A M Frischauf; H Lehrach; A Poustka; N Murray
Journal:  J Mol Biol       Date:  1983-11-15       Impact factor: 5.469

6.  Enzymatic iodination of polypeptides with 125I to high specific activity.

Authors:  J I Thorell; B G Johansson
Journal:  Biochim Biophys Acta       Date:  1971-12-28

7.  Multiple cis-acting DNA regulatory elements mediate hepatic angiotensinogen gene expression.

Authors:  A R Brasier; J E Tate; D Ron; J F Habener
Journal:  Mol Endocrinol       Date:  1989-06

8.  Multiple hormones regulate angiotensinogen messenger ribonucleic acid levels in a rat hepatoma cell line.

Authors:  E Chang; A J Perlman
Journal:  Endocrinology       Date:  1987-08       Impact factor: 4.736

9.  In vivo actions of angiotensin II on glomerular function.

Authors:  R C Blantz; J C Pelayo
Journal:  Fed Proc       Date:  1983-11

10.  Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor.

Authors:  A F Gazdar; W L Chick; H K Oie; H L Sims; D L King; G C Weir; V Lauris
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  6 in total

1.  cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor.

Authors:  C S Narayanan; Y Cui; S Kumar; A Kumar
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 2.  Catecholamines and angiotensinogen gene expression in kidney proximal tubular cells.

Authors:  J S Chan; T T Wang; S L Zhang; X Chen; S Carrière
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  Identification of a novel mouse hepatic 52 kDa protein that interacts with the cAMP response element of the rat angiotensinogen gene.

Authors:  J Wu; Q Jiang; X Chen; X H Wu; J S Chan
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

4.  Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice.

Authors:  S Abdo; C-S Lo; I Chenier; A Shamsuyarova; J G Filep; J R Ingelfinger; S-L Zhang; J S D Chan
Journal:  Diabetologia       Date:  2013-04-23       Impact factor: 10.122

5.  Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice.

Authors:  Anindya Ghosh; Shaaban Abdo; Shuiling Zhao; Chin-Han Wu; Yixuan Shi; Chao-Sheng Lo; Isabelle Chenier; Thierry Alquier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

6.  Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice.

Authors:  Shaaban Abdo; Yixuan Shi; Abouzar Otoukesh; Anindya Ghosh; Chao-Sheng Lo; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2014-05-08       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.